|
Administrative
|
*Material Adverse Change (MAC)
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Administrative
|
|
Pharmacy
|
*Material adverse change (MAC)
|
Pharmacy
|
|
Medical Policy & Clinical Guidelines
|
*Material adverse change (MAC)
|
Medical Policy & Clinical Guidelines
|
*Material adverse change (MAC)
|
Medical Policy & Clinical Guidelines
|
|
Reimbursement Policies
|
*Material adverse change (MAC)
|
Reimbursement Policies
|
*Material adverse change (MAC)
|
Reimbursement Policies
|
- Prior authorization requirement changes effective January 1, 2023 - Medical drug benefit Clinical Criteria updates - Medical Policies and Clinical Utilization Management Guidelines update - Prior authorization updates for medications billed under the medical benefit (Releuko, Vabysmo) - Signature requirements for laboratory orders or requisitions
|
Medicaid
|
- Medical Policies and Clinical Utilization Management Guidelines update - Signature requirements for laboratory orders or requisitions
|
Medicare
|
|
Medicare
|
|
Medicare
|